Summary:
- Ubie Health, an AI-driven healthcare prediction platform, has secured over $125M in funding since its founding in 2017.
- The company has received backing from notable investors such as Google, JAPAN POST CAPITAL Co., Ltd., and NTT DOCOMO, INC.
- Ubie’s medically-validated AI Symptom Checker has garnered over 4 million users in the US and continues to drive partnerships with key advocacy and life sciences companies.
Rewritten Article:
Ubie Health Secures Over $125M in Funding for AI-Driven Healthcare Platform
Ubie Health, a leading NYC-based healthcare prediction platform powered by artificial intelligence, recently announced a significant milestone in its funding journey. Since its inception in 2017, the company has raised over $125 million in cumulative funding, with support from major investors including Google, JAPAN POST CAPITAL Co., Ltd., and NTT DOCOMO, INC.
Driving Innovation in Healthcare
One of Ubie’s flagship products, the AI Symptom Checker, has seen tremendous success in the US market, with over 4 million users leveraging the platform for medical guidance. This innovative tool, which is medically validated, has also facilitated partnerships with key advocacy groups and life sciences companies, showcasing its impact on the healthcare industry.
Furthermore, Ubie’s commitment to empowering individuals and healthcare professionals is evident through its suite of clinical tools designed to streamline workflows and improve health outcomes. With a focus on leveraging medical data to enhance targeting capabilities and digital campaigns, Ubie has become a trusted partner for top life science companies worldwide.
Future Growth and Expansion
As Ubie continues to make strides in the healthcare technology space, the company has been selected to participate in the Mayo Clinic’s Platform Accelerate program. This opportunity signifies Ubie’s dedication to advancing healthcare solutions and driving innovation in the field.
Overall, Ubie Health’s success in securing substantial funding and expanding its reach underscores the company’s commitment to revolutionizing healthcare through AI-driven solutions and cutting-edge technology.
Published by: FinSMEs
Date: 26/06/2025
